Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by GrahamBon Apr 25, 2023 2:16pm
48 Views
Post# 35412899

RE:RE:The other side of 74.5%

RE:RE:The other side of 74.5%Glad you could find what you needed in my post
Highlight away.
Each can interpret facts as they choose
Providing those facts are what I like to do-glad it helped you
on your quest to be more scientific 

Ultimately it is Cardiologists(or hospitals or other purchasing agents ) that pay for the machine that matter to show that it is viable 
This is something that has been missing thus far 
We heard 75-100 sales should be reported on annuals
Now 45
Now is it 6?
Will it be 300,000 revenue or a discount to that

Real sales, and bottom line profits are what moves the needle in a sustained way
 
Testimonials by paid individuals, even if doctors,, invested shareholders, or insiders may be of on point or not.

All IMO
All for entertainment 
Still watching and waiting for sales to buy, but pleased to learn, especially about cognitive biases 
<< Previous
Bullboard Posts
Next >>